PropertyValue
?:abstract
  • This text presents some suggestions regarding the indication of requirements that can serve to define the lawful use of medical practice in the off-label prescription of medications for the treatment of COVID-19, including with regard to patient consent © 2020 Ibero-American Law Institute All rights reserved
is ?:annotates of
?:creator
?:journal
  • Actualidad_Juridica_Iberoamericana
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Off-label pharmaceutical drug prescription in Brazilian law: Medical liability and challenges in times of COVID-19
?:type
?:who_covidence_id
  • #831602
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ft77x6cx>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ft77x6cx>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all